Twist Bioscience Corp TWST:NASDAQ

Last Price$37.95NASDAQ Previous Close - Last Trade as of 3:59PM ET 5/29/20

Today's Change+2.13(5.95%)
Bid (Size)$38.00 (1)
Ask (Size)$39.00 (5)
Day Low / High$35.25 - 38.03
Volume511.7 K

View Biotechnology IndustryPeer Comparison as of 05/29/2020


Twist Bioscience Corp ( NASDAQ )

Price: $37.95
Change: +2.13 (5.95%)
Volume: 511.7 K
3:59PM ET 5/29/2020

Sangamo Therapeutics Inc ( NASDAQ )

Price: $11.19
Change: -0.25 (2.19%)
Volume: 2.1 M
3:59PM ET 5/29/2020

Dicerna Pharmaceuticals Inc ( NASDAQ )

Price: $21.57
Change: +0.65 (3.11%)
Volume: 723.1 K
3:59PM ET 5/29/2020

Editas Medicine Inc ( NASDAQ )

Price: $27.07
Change: -0.22 (0.81%)
Volume: 1.0 M
3:59PM ET 5/29/2020

Ligand Pharmaceuticals Inc ( NASDAQ )

Price: $101.57
Change: +0.78 (0.77%)
Volume: 293.6 K
4:00PM ET 5/29/2020

Read more news Recent News

Twist Bioscience Soars After Identifying Antibodies With Potential to be Used in Diagnostic Testing
1:05PM ET 5/06/2020 MT Newswires

Shares of Twist Bioscience (TWST) surged 16% intraday after the company said it identified "competitive antibodies" to SARS-CoV-2, the virus that causes...

Twist Bioscience Says Two of Its SARS-CoV-2 RNA Sequences Added to FDA's Reference Materials
11:01AM ET 3/25/2020 MT Newswires

Twist Bioscience (TWST), a synthetic biology company, said Wednesday that two of its synthetic SARS-CoV-2 RNA reference sequences have been added to the US...

Twist Bioscience Offers Two New Synthetic COVID-19 Controls
3:34PM ET 3/12/2020 MT Newswires

Twist Bioscience (TWST) said Thursday that it is offering two synthetic SARS-CoV-2 RNA Controls for developing, verifying and validating diagnostic tests...

Twist Bioscience Collaborates With Miroculus Over Next-Generation Sequencing
10:42AM ET 2/25/2020 MT Newswires

Twist Bioscience (TWST), a manufacturer of synthetic DNA, said Tuesday it agreed to collaborate with Miroculus, a developer of next-generation sequencing,...

Company Profile

Business DescriptionTwist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA. View company web site for more details
Address681 Gateway Boulevard
San Francisco, California 94080
Number of Employees289
Recent SEC Filing05/28/20204
Chairman, President & Chief Executive OfficerEmily Marine Leproust
Chief Operating OfficerPatrick Weiss
Chief Financial OfficerJames M. Thorburn
Chief Technology OfficerBill James Peck

Company Highlights

Price Open$36.00
Previous Close$35.82
52 Week Range$18.52 - 42.17
Market Capitalization$1.6 B
Shares Outstanding41.0 M
SectorHealth Technology
Next Earnings Announcement08/06/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$3.94
Beta vs. S&P 500N/A
Revenue$25.4 M
Net Profit Margin-222.66%
Return on Equity-84.27%

Analyst Ratings as of 05/08/2020

Consensus RecommendationConsensus Icon
Powered by Factset